Our study demonstrates that BYHWD ameliorates Alzheimer's disease pathology by modulating the gut microbiota and suppressing the C/EBPβ–AEP signaling pathway. This evidence concerns the gene CEBPB and early-onset autosomal dominant Alzheimer disease.